UNSPSC 51393315: Sulukast

This classification denotes a bronchodilator with the molecular formula C25H36N4O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M652A5186T, chemically known as 3-(((1r,2e,4z)-1-((alphas)-alpha-hydroxy-m-1h-tetrazol-5-ylbenzyl)-2,4-tetradecadienyl)thio)propionic acid but generally known as sulukast, which bears US NIH Compound Identifier 6436123. European Medicines Agency schedules Sulukast in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10766MIG.

UNSPSC 51393315 Sulukast is a Commodity code that does not align with recent state and local procurement activity. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits Naloxone and Safe Drug Deactivation Systems, not sulukast or related pharmaceutical products. Naloxone is an opioid antagonist used in emergency overdose response, and drug deactivation systems are medical waste or pharmaceutical disposal equipment; neither falls within the scope of sulukast, which is a leukotriene antagonist used in asthma and allergic rhinitis management. The mismatch suggests either a miscoding error in the procurement office's taxonomy assignment or that the state and local opportunity record does not accurately reflect how Seminole County tagged the solicitation internally.

The code shows little relevant recent activity supporting genuine sulukast procurement at the state and local level. No additional opportunities tagged to UNSPSC 51393315 appear in the source. Without a representative pipeline of actual sulukast solicitations—whether from state departments of health, county health agencies, school districts with asthma-management programs, or other issuing bodies—the code does not support a targeted pursuit strategy at this time. Monitor for corrected or clarified opportunities, but treat current visibility as negligible for business development purposes.